Atossa Therapeutics
ATOS
#9970
Rank
โ‚น4.10 B
Marketcap
โ‚น476.18
Share price
-2.85%
Change (1 day)
730.18%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -โ‚น21.52

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น23.30. In 2024 the company made an earnings per share (EPS) of -โ‚น18.64 an increase over its 2023 EPS that were of -โ‚น22.36.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น21.5215.48%
2024-โ‚น18.64-16.67%
2023-โ‚น22.3614.29%
2022-โ‚น19.5716.67%
2021-โ‚น16.77-90.86%
2020-โ‚น183.58-2.96%
2019-โ‚น189.17-63.09%
2018-โ‚น512.52-49.63%
2017-โ‚น1,018-57.87%
2016-โ‚น2,415-74.01%
2015-โ‚น9,293-9.18%
2014-โ‚น10,232-12.86%
2013-โ‚น11,74170.73%
2012-โ‚น6,87734.08%
2011-โ‚น5,129263.47%
2010-โ‚น1,411

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,038-4,555.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น826.56-3,648.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น981.25-4,312.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น82.00 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น19.57-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA